A Double Blind, Randomized, Parallel Study to Assess the Effects of Aliskiren/Amlodipine and Amlodipine Monotherapy on Ankle Foot Volume (AFV) in Patients naïve to Trial Drugs With Mild to Moderate Hypertension.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Aliskiren/amlodipine; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Novartis Pharmaceuticals
- 03 May 2012 Inclusion and exclusion criteria amended as reported by European Clinical Trials Database record.
- 23 Dec 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Dec 2011 Planned end date changed from 1 Dec 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.